R

Roivant Sciences Ltd
D

ROIV

20.210
USD
0.32
(1.61%)
مغلق
حجم التداول
186,516
الربح لكل سهم
-1
العائد الربحي
-
P/E
-19
حجم السوق
13,801,040,026
الأخبار المقالات

العنوان: Roivant Sciences Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.